Silva Pharmaceuticals Limited (DSE:SILVAPHL)
Bangladesh · Delayed Price · Currency is BDT 9.60
+0.10 (1.05%)
At close: Mar 4, 2026
Silva Pharmaceuticals Market Cap
Silva Pharmaceuticals has a market cap or net worth of 1.31 billion as of March 4, 2026.
Market Cap
1.31B
Enterprise Value
1.23B
Revenue
356.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
9.60
Market Cap Chart
Since October 10, 2018, Silva Pharmaceuticals's market cap has decreased from 3.77B to 1.31B, a decrease of -65.24%. That is a compound annual growth rate of -13.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 1.30B | 1.06% |
| Dec 30, 2025 | 1.28B | -7.84% |
| Dec 30, 2024 | 1.39B | -52.78% |
| Dec 28, 2023 | 2.95B | - |
| Dec 29, 2022 | 2.95B | 20.67% |
| Dec 30, 2021 | 2.44B | -2.19% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Asiatic Laboratories | 7.38B |
| Orion Pharma | 7.02B |
| Navana Pharmaceuticals | 6.23B |
| Techno Drugs | 3.89B |
| Ambee Pharmaceuticals | 1.80B |
| Pharma Aids | 1.67B |
| Indo-Bangla Pharmaceuticals | 1.55B |
| Libra Infusions | 1.42B |